3,4,5-Trimethoxyamphetamine |
hallucinogen |
22nd ECDD (1985) - Critical review |
3,4-Methylenedioxyamphetamine |
stimulant |
22nd ECDD (1985) - Critical review |
3,4-Methylenedioxymethamphetamine |
stimulant |
22nd ECDD (1985) - Critical review |
3,4-Methylenedioxypyrovalerone |
stimulant |
36th ECDD (2014) - Critical review |
3-Allyl-1-methyl-4-phenyl-4-propionoxypiperidine |
opioid |
9th ECDD (1959) - Critical review |
3-CMC |
stimulant |
2023, 46th ECDD Critical Review
|
3-dimethylamino-1,1-di-(2'thienyl)-1-butene |
opioid |
4th ECDD (1954) - Critical review |
3-ethylamino-1,1-di-(2'thienyl)-1-butene |
opioid |
4th ECDD (1954) - Critical review |
3-fluorophenmetrazine |
stimulant |
43rd ECDD (2020) - Critical review |
3-Hydroxy-N-methylmorphinan |
opioid |
3rd ECDD (1952) - Critical review |
3-Hydroxy-N-phenethylmorphinan |
opioid |
6th ECDD (1956) - Critical review |
3-Methoxy-N-methylmorphinan |
opioid |
3rd ECDD (1952) - Critical review |
3-methoxyphencyclidine |
dissociative |
43rd ECDD (2020) - Critical review |
3-Methyl-2,2-diphenyl-4-morpholinobutyrylpyrrolidine |
opioid |
7th ECDD (1957) - Critical review |
3-Methylfentanyl |
opioid |
24th ECDD (1988) - Critical review |
3-Methylthiofentanyl |
opioid |
26th ECDD (1989) - Critical review |
3-MMC |
stimulant |
38th ECDD (2016)- Critical Review, 45th ECDD (2022) - Critical review |
3-piperidino-1,1-di-(2'-thienyl)-1-butene |
opioid |
7th ECDD (1957) - Critical review |